CDC vaccine advisers unanimously vote to recommend Moderna vaccine for people ages 6-17
(CNN) Vaccine advisers to the US Centers for Disease Control and Prevention voted on Thursday to support recommending the two-dose Moderna Covid-19 vaccine for use in people ages 6 through 17 years old.
All 15 voting members of the CDC's Advisory Committee on Immunization Practices (ACIP) voted yes on the statements:"A two-dose Moderna COVID-19 vaccine (50mcg) is recommended for children ages 6 -- 11 years, under the EUA issued by the FDA."
"A two-dose Moderna COVID-19 vaccine (100mcg) is recommended for adolescents ages 12 -- 17 years, under the EUA issued by the FDA."
Overall, the data presented from the company showed that most children got the vaccine without incident.
During the pandemic over 5.1 million Covid-19 cases have occurred among children ages 5 through 11 according to a presentation at the meeting from the CDC's Dr. Sara Oliver.
Following the ACIP vote, CDC Director Dr. Rochelle Walensky will decide whether to sign off on the ACIP recommendation.
For children ages 6 through 11, the Moderna vaccine is administered as a two-dose series at 50 micrograms per dose.
People ages 6 to 17 were already eligible to be vaccinated with the Pfizer/BioNTech Covid-19 vaccine.
We know that the benefits outweigh the risks for mRNA Covid-19 vaccine in all ages," Oliver said.
Some children and adolescents, depending on their age, who have received the Pfizer Covid-19 vaccine are eligible for a booster dose.
For children ages 6 through 11, who will get a bigger dosage size at 50 micrograms, the vial has a dark blue cap as well, but the border is purple.
Several vaccine advisory committee members urged Moderna and Pfizer to simplify the Covid-19 vaccine vial design.